COVID-19 and Medical Biotechnology

摘要

Novel coronavirus disease (COVID-19) pandemic, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV-2), became a global challenge . The disease which emerged in Wuhan, China, late 2019, has affected more than 6 million individuals in almost all countries and regions, leading to death in more than 350,000 only in a 6-month period (Date: June 1st, 2020). It should be mentioned that SARS-CoV-2 is responsible for the 3rd respiratory syndrome, caused by coronaviruses during last two decades, while SARS-CoV and Middle East Respiratory Syndrome coronavirus (MERS-CoV) were both connected to the emergence of severe respiratory syndromes in 2003 and 2012, respectively . Meanwhile there is no effective treatment or vaccine for the disease.